Top news of the week: 26.05.2020.
Antibody, Smallpox, Vaccination, Malaria, Vaccine, Virus
Healthcare
RT @HelenBranswell: Just as we need to temper our expectations about how quickly we can get #Covid19 vaccines, we should be realistic about what first generation vaccines will be able to do. Blocking all infection is unlikely with a vaccine for a respiratory pathogen. https://t.co/FeO6ukvgDV
OpenThe world needs Covid-19 vaccines. It may also be overestimating their power
Vaccines against the disease are desparately needed, but they won’t necessarily prevent all or even most infections, experts say.
RT @ScottGottliebMD: A window into efforts to produce a covid vaccine at Pfizer, where I serve on the company board of directors; and where many Pfizer colleagues are working hard to contribute to the kinds of technological innovations that'll ultimately vanquish this threat. https://t.co/50KWF2YI8i
OpenThe inside story behind the pandemic, the CEO and a promising, unproven treatment.
The inside story behind the pandemic, the CEO and a promising, unproven treatment.
Biopharma Update on the Novel Coronavirus: May 22 https://t.co/KdMukjd8eI https://t.co/GO8QIoXlje
OpenBiopharma Update on the Novel Coronavirus: May 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 22, 2020.
Jeff Bezos joins $76M round for secretive biotech startup led by Isilon co-founder, Stanford scientist #BioTech #startup via https://t.co/2sI0UxJbpn https://t.co/BtDihPUzGX
OpenJeff Bezos joins $76M round for secretive biotech startup led by Isilon co-founder, Stanford scientist
Parag Mallick spent more than 20 years studying the intersection of software engineering and life sciences to better understand predictive and personalized medicine. Then, one weekend…
Coronavirus vaccine trials have delivered their first results—but their promise is still unclear https://t.co/VffjWdnb6w https://t.co/zztn0kBzXI
OpenCoronavirus Vaccine Trials Have Delivered Their First Results—But Their Promise Is Still Unclear
Scientists urge caution over hints of success emerging from small human and animal studies
Coronavirus study in China shows CanSino's vaccine spurs immune response https://t.co/uoBLDQ6gjJ https://t.co/Y1x2paBPyG
OpenCoronavirus study in China shows CanSino's vaccine spurs immune responses
But researchers, who conducted the trial in a locked-down Wuhan, aren't yet certain whether those responses will actually confer protection against coronavirus infection.
Innovation Opportunities in Data, AI, AR, Robots, Biotech, More [Overview] #BioTech #innovation via https://t.co/2sI0UxJbpn https://t.co/FsOm1bQcK0
OpenInnovation Opportunities in Data, AI, AR, Robots, Biotech, More [Overview]
![Innovation Opportunities in Data, AI, AR, Robots, Biotech, More [Overview]](https://hackernoon.com/drafts/8zbo3yxx.png)
Digital Technology is everywhere and it is redefining how we live, communicate, and work. Most importantly, it accelerates how we innovate.
Sorrento Responds to Criticism of COVID-19 Neutralizing Antibodies https://t.co/cH0PKsaCdb https://t.co/ioEtugRebP
OpenSorrento Responds to Criticism of COVID-19 Neutralizing Antibodies
Henry Li, Sorrento's co-founder, director, president and chief executive officer, did a follow-up interview with BioSpace to discuss the news and speculation surrounding it.